98%
921
2 minutes
20
Infection with influenza A (FluA) virus usually leads to secondary infection with streptococcus pneumoniae (s. pneumoniae). It is urgent to develop rapid, highly sensitive, simultaneous and universal point-of-care testing (POCT) techniques for FluA and s. pneumoniae. We developed a two-channel surface-enhanced Raman scattering (SERS)-lateral flow assay (LFA) technique based on wheat germ agglutinin (WGA)-modified magnetic SERS nanotags (FeO@Au-WGA), for detection of FluA and s. pneumoniae. The detection limits were 14 copies/mL for FluA and 10 cells/mL for s. pneumoniae, and the sensitivity was about 100 times higher than the visual signals. It was used to detect 80 FluA and s. pneumoniae positive throat swabs/sputum samples and 30 negative samples, with a diagnostic accuracy of 100 %, which was 19 % higher than that of commercial colloidal gold-LFA strips. Therefore, the proposed platform has a strong clinical application potential in the rapid, accurate, highly sensitive and universal detection of FluA and s. pneumoniae.
Download full-text PDF |
Source |
---|---|
http://dx.doi.org/10.1016/j.nano.2025.102853 | DOI Listing |
Nanomedicine
August 2025
State Key Laboratory of Pathogen and Biosecurity, Academy of Military Medical Sciences, Beijing, China. Electronic address:
Infection with influenza A (FluA) virus usually leads to secondary infection with streptococcus pneumoniae (s. pneumoniae). It is urgent to develop rapid, highly sensitive, simultaneous and universal point-of-care testing (POCT) techniques for FluA and s.
View Article and Find Full Text PDFFront Public Health
August 2025
Department of Center for Precision Medicine, The Central Hospital of Yongzhou, Yongzhou, China.
Background: Acute respiratory infections (ARIs) are major global public health concerns. Understanding the epidemiological characteristics and evolution patterns of respiratory pathogens before and after the coronavirus disease 2019 (COVID-19) pandemic is crucial for disease control and prevention. This study identified the epidemiological characteristics and pathogen distribution in hospitalized patients with ARIs in Yongzhou, China.
View Article and Find Full Text PDFMicrobiol Spectr
August 2025
Department of Laboratory Medicine and Genetics, Samsung Medical Center, Sungkyunkwan University School of Medicine, Gangnam-gu, Seoul, Republic of Korea.
Accurate and rapid diagnostic assays that simultaneously detect severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and influenza A/B are crucial for effective clinical management and infection control. In the present study, we evaluated the cobas SARS-CoV-2 & Influenza A/B v2 assay (Roche Diagnostics, Basel, Switzerland) using the Roche cobas 5800 system, comparing it to the Allplex SARS-CoV-2/FluA/FluB/RSV assay (Seegene, Seoul, Republic of Korea). A total of 871 nasopharyngeal swab specimens, including 164 SARS-CoV-2-positive, 76 influenza A-positive, 77 influenza B-positive, and 554 negative specimens, were tested using the cobas and Allplex assays in parallel.
View Article and Find Full Text PDFBMC Infect Dis
July 2025
Pediatric Infectious Disease Research Center, Tehran University of Medical Sciences, Tehran, Iran.
Background: The COVID-19 pandemic has profoundly altered the epidemiology of viral respiratory infections; however, other respiratory viruses besides SARS-CoV-2 continue to cause illness in hospitalized children. This study aimed to assess the frequency of common respiratory viruses, other than SARS-CoV-2, in children hospitalized with respiratory symptoms during the COVID-19 pandemic, and to examine rates of co-infection with multiple viruses.
Materials And Methods: This study included 92 pediatric patients admitted to the Children's Medical Center in Tehran, Iran, between December 2021 and March 2022, all of whom tested negative for SARS-CoV-2 by Real-time PCR.
BMC Infect Dis
July 2025
Department of Emergency, Guangdong Provincial Clinical Research Center for Child Health, Guangzhou Women and Children's Medical Center, Guangzhou Medical University, Guangzhou, Guangdong, 510623, China.
Objective: To investigate the epidemiological characteristics of pediatric respiratory pathogens in Guangzhou, China, from 2018 to 2023 in the context of the COVID-19 Pandemic and to evaluate the impact of non-pharmaceutical interventions (NPIs) on the transmission dynamics and seasonal patterns of respiratory pathogens.
Methods: A retrospective analysis was conducted at Guangzhou Women and Children's Medical Center between January 2018 and December 2023. Pediatric patients who underwent the respiratory pathogens tests were enrolled in the study and divided into four groups by age: Infant group, Toddler group, Preschool group, and School-age group.